About Eidos Therapeutics & BridgeBio Pharma Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3... stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases. BridgeBio...
About Eidos Therapeutics & BridgeBio Pharma Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3... stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases. BridgeBio...
About Calcilytix & BridgeBio Pharma Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is developing... clinical study and has received Orphan Drug and Fast Track Designations from the US FDA. BridgeBio is a biopharmaceutical...
Type: Remote Job Contract Type: Full-time Job Seniority Level: Entry level About BridgeBioBridgeBio is a biopharmaceutical... and company culture, visit us at https://bridgebio.com Who You Are The Computational Genetics team is seeking a full-time...
About BridgeBioBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver... for Commercial (primarily Market Access) Teams that report to the BridgeBio family of subsidiary companies Contribute to the...
About BridgeBioBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver... with Revenue Recognition Accounting Guidelines (ASC 606) is a plus No matter your role at BridgeBio, successful team members...
About BridgeBioBridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver... projects and manage other responsibilities as appropriate No matter your role at BridgeBio, successful team members...
therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M... in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The...
About Eidos Therapeutics & BridgeBio Pharma Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3... stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases. BridgeBio...
therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M... in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The...